Expression of epidermal CAMP changes in parallel with permeability barrier status

Journal of Investigative Dermatology

Volumn 131, Issue 11, 2011, Pages 2263-2270

  Rodriguez Martin, Marina ^a,b   Martin Ezquerra, Gemma ^b,c   Man, Mao Qiang ^b   Hupe, Melanie ^b   Youm, Jong Kyung ^b   MacKenzie, Donald S ^b   Cho, Soyun ^b,d   Trullas, Carles ^e   Holleran, Walter M ^b   Radek, Katherine A ^f   Elias, Peter M ^b  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d Seoul National University   (South Korea)

^e ISDIN   (Spain)

^f LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA DEFENSIN 3; CALCIPOTRIOL; CATESTATIN; CATHELICIDIN; CYCLIC AMP; IMIQUIMOD; POLYPEPTIDE ANTIBIOTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EPIDERMIS; FEMALE; GRAM POSITIVE BACTERIUM; HOMEOSTASIS; IMMUNOHISTOCHEMISTRY; LAMELLAR BODY; MALE; MENTAL STRESS; MOUSE; NONHUMAN; PERMEABILITY BARRIER; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT DURATION; UPREGULATION;

EID: 80054770001     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2011.210     Document Type: Article

References (67)

1. Aberg KM, Man MQ, Gallo RL et al. (2008) Co-regulation and interdependence of the mammalian epidermal permeability and antimicrobial barriers. J Invest Dermatol 128:917-25 (Pubitemid 351374295)
2. Aberg KM, Radek KA, Choi EH et al. (2007) Psychological stress downregulates epidermal antimicrobial peptide expression and increases severity of cutaneous infections in mice. J Clin Invest 117:3339-49 (Pubitemid 350096990)
3. Aly R, Shirley C, Cunico B et al. (1978) Effect of prolonged occlusion on the microbial flora, pH, carbon dioxide and transepidermal water loss on human skin. J Invest Dermatol 71:378-81 (Pubitemid 9104276)
4. Ambach A, Bonnekoh B, Nguyen M et al. (2004) Imiquimod, a Toll-like receptor-7 agonist, induces perforin in cytotoxic T lymphocytes in vitro. Mol Immunol 40:1307-14 (Pubitemid 38456982)
5. Arikawa J, Ishibashi M, Kawashima M et al. (2002) Decreased levels of sphingosine, a natural antimicrobial agent, may be associated with vulnerability of the stratum corneum from patients with atopic dermatitis to colonization by Staphylococcus aureus. J Invest Dermatol 119:433-9 (Pubitemid 35001954)
6. Barland CO, Elias PM, Ghadially R (2005) The aged epidermal barrier: Basis for functional abnormalities. In: Skin Barrier. (Elias PM, Feingold KR, eds) Vol New York: Marcel Dekker, 535-52
7. Barland CO, Zettersten E, Brown BS et al. (2004) Imiquimod-induced interleukin-1 alpha stimulation improves barrier homeostasis in aged murine epidermis. J Invest Dermatol 122:330-6 (Pubitemid 38281052)
8. Bibel DJ, Miller SJ, Brown BE et al. (1989) Antimicrobial activity of stratum corneum lipids from normal and essential fatty acid-deficient mice. J Invest Dermatol 92:632-8 (Pubitemid 19122123)
9. Bikle DD (2010) Vitamin D and the skin. J Bone Miner Metab 28:117-30
10. Bikle DD, Teichert A, Arnold LA et al. (2010) Differential regulation of epidermal function by VDR coactivators. J Steroid Biochem Mol Biol 121:308-13
11. Braff MH, Di Nardo A, Gallo RL (2005) Keratinocytes store the antimicrobial peptide cathelicidin in lamellar bodies. J Invest Dermatol 124:394-400 (Pubitemid 40175887)
12. Chamlin SL, Kao J, Frieden IJ et al. (2002) Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: Changes in barrier function provide a sensitive indicator of disease activity. J Am Acad Dermatol 47:198-208
13. Choi EH, Brown BE, Crumrine D et al. (2005) Mechanisms by which psychologic stress alters cutaneous permeability barrier homeostasis and stratum corneum integrity. J Invest Dermatol 124:587-95 (Pubitemid 40381582)
14. Choi EH, Demerjian M, Crumrine D et al. (2006) Glucocorticoid blockade reverses psychological stress-induced abnormalities in epidermal structure and function. Am J Physiol Regul Integr Comp Physiol 291:R1657-62
15. Choi EH, Man MQ, Xu P et al. (2007) Stratum corneum acidification is impaired in moderately aged human and murine skin. J Invest Dermatol 127:2847-56 (Pubitemid 350134813)
16. Cork MJ, Robinson DA, Vasilopoulos Y et al. (2006) New perspectives on epidermal barrier dysfunction in atopic dermatitis: Gene-environment interactions. J Allergy Clin Immunol 118:3-21; quiz 22-3 (Pubitemid 43946484)
17. Corsini E, Racchi M, Lucchi L et al. (2009) Skin immunosenescence: Decreased receptor for activated C kinase-1 expression correlates with defective tumour necrosis factor-alpha production in epidermal cells. Br J Dermatol 160:16-25
18. de Jongh GJ, Zeeuwen PL, Kucharekova M et al. (2005) High expression levels of keratinocyte antimicrobial proteins in psoriasis compared with atopic dermatitis. J Invest Dermatol 125:1163-73
19. Denda M, Tsuchiya T, Elias PM et al. (2000) Stress alters cutaneous permeability barrier homeostasis. Am J Physiol Regul Integr Comp Physiol 278:R367-72 (Pubitemid 30129626)
20. Denda M, Tsuchiya T, Hosoi J et al. (1998) Immobilization-induced and crowded environment-induced stress delay barrier recovery in murine skin. Br J Dermatol 138:780-5 (Pubitemid 28231517)
21. Drake DR, Brogden KA, Dawson DV et al. (2008) Thematic review series: Skin lipids. Antimicrobial lipids at the skin surface. J Lipid Res 49:4-11
22. Elias PM (2005) Stratum corneum defensive functions: An integrated view. J Invest Dermatol 125:183-200 (Pubitemid 41648149)
23. Elias PM (2007) The skin barrier as an innate immune element. Sem Immunopathol 29:3-14 (Pubitemid 47596384)
24. Elias PM, Choi EH (2005) Interactions among stratum corneum defensive functions. Exp Dermatol 14:719-26 (Pubitemid 41419458)
25. Elias PM, Schmuth M (2009) Abnormal skin barrier in the etiopathogenesis of atopic dermatitis. Curr Opin Allergy Clin Immunol 9:437-46
26. Elias PM, Steinhoff M (2008) "Outside-to-inside" (and now back to "outside") pathogenic mechanisms in atopic dermatitis. J Invest Dermatol 128:1067-70 (Pubitemid 351543225)
27. Eyerich K, Pennino D, Scarponi C et al. (2009) IL-17 in atopic eczema: Linking allergen-specific adaptive and microbial-triggered innate immune response. J Allergy Clin Immunol 123:59-66 e4
28. Georgel P, Crozat K, Lauth X et al. (2005) A toll-like receptor 2-responsive lipid effector pathway protects mammals against skin infections with Gram-positive bacteria. Infect Immun 73:4512-21 (Pubitemid 41105605)
29. Ghadially R, Brown BE, Sequeira-Martin SM et al. (1995) The aged epidermal permeability barrier. Structural, functional, and lipid biochemical abnormalities in humans and a senescent murine model. J Clin Invest 95:2281-90
30. Glaser R, Meyer-Hoffert U, Harder J et al. (2009a) The antimicrobial protein psoriasin (S100A7) is upregulated in atopic dermatitis and after experimental skin barrier disruption. J Invest Dermatol 129:641-9
31. Glaser R, Navid F, Schuller W et al. (2009b) UV-B radiation induces the expression of antimicrobial peptides in human keratinocytes in vitro and in vivo. J Allergy Clin Immunol 123:1117-23
32. Grayson S, Johnson-Winegar AG, Wintroub BU et al. (1985) Lamellar bodyenriched fractions from neonatal mice: Preparative techniques and partial characterization. J Invest Dermatol 85:289-94 (Pubitemid 15248010)
33. Grether-Beck S, Felsner I, Brenden H et al. (2011) Urea uptake enhances barrier function and antimicrobial defense in humans by regulating epidermal gene expression. J Invest Dermatol (in press)
34. Haratake A, Uchida Y, Schmuth M et al. (1997) UVB-induced alterations in permeability barrier function: Roles for epidermal hyperproliferation and thymocyte-mediated response. J Invest Dermatol 108:769-75 (Pubitemid 27192352)
35. Hatano Y, Man MQ, Uchida Y et al. (2009) Maintenance of an acidic stratum corneum prevents emergence of murine atopic dermatitis. J Invest Dermatol 129:1824-35
36. Holick MF (1987) Photosynthesis of vitamin D in the skin: Effect of environmental and life-style variables. Fed Proc 46:1876-82 (Pubitemid 17075935)
37. Holleran WM, Uchida Y, Halkier-Sorensen L et al. (1997) Structural and biochemical basis for the UVB-induced alterations in epidermal barrier function. Photodermatol Photoimmunol Photomed 13:117-28 (Pubitemid 28023149)
38. Hong SP, Kim MJ, Jung MY et al. (2008) Biopositive effects of low-dose UVB on epidermis: Coordinate upregulation of antimicrobial peptides and permeability barrier reinforcement. J Invest Dermatol 128:2880-7
39. Howell MD (2007) The role of human beta defensins and cathelicidins in atopic dermatitis. Curr Opin Allergy Clin Immunol 7:413-7 (Pubitemid 47415285)
40. Kao JS, Garg A, Mao-Qiang M et al. (2001) Testosterone perturbs epidermal permeability barrier homeostasis. J Invest Dermatol 116:443-51
41. Kobayashi M, Yoshiki R, Sakabe J et al. (2009) Expression of toll-like receptor 2, NOD2 and dectin-1 and stimulatory effects of their ligands and histamine in normal human keratinocytes. Br J Dermatol 160:297-304
42. Komuves LG, Schmuth M, Fowler AJ et al. (2002) Oxysterol stimulation of epidermal differentiation is mediated by liver X receptor-beta in murine epidermis. J Invest Dermatol 118:25-34 (Pubitemid 34107420)
43. Korting HC, Hubner K, Greiner K et al. (1990) Differences in the skin surface pH and bacterial microflora due to the long-term application of synthetic detergent preparations of pH 5.5 and pH 7.0. Results of a crossover trial in healthy volunteers. Acta Derm Venereol 70:429-31 (Pubitemid 20262795)
44. Lai Y, Gallo RL (2008) Toll-like receptors in skin infections and inflammatory diseases. Infect Disord Drug Targets 8:144-55
45. Man M, Hupe M, Mackenzie D et al. (2011) A topical Chinese herbal mixture improves epidermal permeability barrier function in normal murine skin. Exp Dermatol 20:285-8
46. Man MQ, Fowler AJ, Schmuth M et al. (2004) Peroxisome- proliferatoractivated receptor (PPAR)-gamma activation stimulates keratinocyte differentiation. J Invest Dermatol 123:305-12 (Pubitemid 38951825)
47. McInturff JE, Modlin RL, Kim J (2005) The role of toll-like receptors in the pathogenesis and treatment of dermatological disease. J Invest Dermatol 125:1-8 (Pubitemid 40981417)
48. Miller SJ, Aly R, Shinefeld HR et al. (1988) In vitro and in vivo antistaphylococcal activity of human stratum corneum lipids. Arch Dermatol 124:209-15 (Pubitemid 18054501)
49. Morizane S, Yamasaki K, Kabigting FD et al. (2010) Kallikrein expression and cathelicidin processing are independently controlled in keratinocytes by calcium, vitamin D(3), and retinoic acid. J Invest Dermatol 130:1297-306
50. Nizet V, Ohtake T, Lauth X et al. (2001) Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 414:454-7 (Pubitemid 34173727)
51. Nomura I, Goleva E, Howell MD et al. (2003) Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J Immunol 171:3262-9
52. Oren A, Ganz T, Liu L et al. (2003) In human epidermis, beta-defensin 2 is packaged in lamellar bodies. Exp Mol Pathol 74:180-2 (Pubitemid 36438667)
53. Peric M, Koglin S, Kim SM et al. (2008) IL-17A enhances vitamin D3-induced expression of cathelicidin antimicrobial peptide in human keratinocytes. J Immunol 181:8504-12
54. Proksch E, Brandner JM, Jensen JM (2008) The skin: An indispensable barrier. Exp Dermatol 17:1063-72
55. Proksch E, Jensen JM, Elias PM (2003) Skin lipids and epidermal differentiation in atopic dermatitis. Clin Dermatol 21:134-44 (Pubitemid 36428984)
56. Radek K, Gallo R (2007) Antimicrobial peptides: Natural effectors of the innate immune system. Semin Immunopathol 29:27-43 (Pubitemid 47596388)
57. Radek KA, Elias PM, Taupenot L et al. (2010) Neuroendocrine nicotinic receptor activation increases susceptibility to bacterial infections by suppressing antimicrobial peptide production. Cell Host Microbe 7:277-89
58. Radek KA, Lopez-Garcia B, Hupe M et al. (2008) The neuroendocrine peptide catestatin is a cutaneous antimicrobial and induced in the skin after injury. J Invest Dermatol 128:1525-34 (Pubitemid 351693209)
59. Reed JT, Elias PM, Ghadially R (1997) Integrity and permeability barrier function of photoaged human epidermis. Arch Dermatol 133:395-6 (Pubitemid 27142342)
60. Sauder DN (1990) The role of epidermal cytokines in inflammatory skin diseases. J Invest Dermatol 95:27S-8S
61. Sauder DN (2004) Mechanism of action and emerging role of immune response modifier therapy in dermatologic conditions. J Cutan Med Surg 8(Suppl 3):3-12 (Pubitemid 40685108)
62. Schauber J, Gallo RL (2008) The vitamin D pathway: A new target for control of the skin's immune response? Exp Dermatol 17:633-9 (Pubitemid 352044354)
63. Schroder JM, Harder J (2006) Antimicrobial skin peptides and proteins. Cell Mol Life Sci 63:469-86
64. Takeuchi O, Akira S (2009) Innate immunity to virus infection. Immunol Rev 227:75-86
65. Yano S, Banno T, Walsh R et al. (2008) Transcriptional responses of human epidermal keratinocytes to cytokine interleukin-1. J Cell Physiol 214:1-13 (Pubitemid 350220053)
66. Ye J, Calhoun C, Feingold K et al. (1999) Age-related changes in the IL-1 gene family and their receptors before and after barrier abrogation. J Invest Dermatol 112:543
67. Zasloff M (2005) Sunlight, vitamin D, and the innate immune defenses of the human skin. J Invest Dermatol 125:xvi-i